# A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels

> **NCT04616222** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 200 (estimated)

## Conditions studied

- Transposition of Great Vessels

## Interventions

- **DRUG:** CELSIOR® group
- **DRUG:** Saint-Thomas group

## Key facts

- **NCT ID:** NCT04616222
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04616222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04616222, "A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04616222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*